<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903341</url>
  </required_header>
  <id_info>
    <org_study_id>38RC17.399</org_study_id>
    <nct_id>NCT03903341</nct_id>
  </id_info>
  <brief_title>The Role of the Upper Colliculus in the Idiopathic Blepharospasm</brief_title>
  <acronym>COLL-BSP</acronym>
  <official_title>The Role of the Upper Colliculus in the Idiopathic Blepharospasm : a Pilot Study in Functional MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This pilot study aims at investigating the role of superior colliculus in patients with
      idiopathic blepharospasm (BSP) de novo, compared to healthy subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to investigate the function of the superior colliculus (SC)
      related to visual stimulation by means of fMRI (functional magnetic resonance imaging) in
      patients with idiopathic BSP compared to healthy subjects. The hypothesis is that SC function
      is impaired in BSP (role of biomarker of SC).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 9, 2018</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual pathways fMRI</measure>
    <time_frame>In a five months period after inclusion</time_frame>
    <description>To measure the bold signal in superior colliculus and lateral geniculate corpus</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Blepharospasm, Benign Essential</condition>
  <arm_group>
    <arm_group_label>idiopathic blepharospasm (BSP) de novo</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>bold signal in visual pathway</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>bold signal in visual pathway</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>bold signal in visual pathway</description>
    <arm_group_label>Healthy subjects</arm_group_label>
    <arm_group_label>idiopathic blepharospasm (BSP) de novo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non treated idiopathic blepharospasm

          -  Age: 30- 70 years

        Exclusion Criteria:

          -  Under the following treatments: Botulin toxin, anticholinergic, benzodiazepines,
             baclofen, beta- and alpha-blockers collyrium

          -  No MRI Contraindication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sara Meoni, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>chu gRENOBLE aLPES</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sara Meoni, MD, PhD</last_name>
    <phone>+ 33 4 76 76 94 52</phone>
    <email>smeoni@chu-grenoble.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Pelissier, Master</last_name>
      <phone>+ 3 4 76 76 94 59</phone>
      <email>ppelissier@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Elena Moro, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Val√©rie Fraix, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Castrioto, MD-PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie Fournier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Superior colliculus</keyword>
  <keyword>fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blepharospasm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

